Search research articles
Contact Us
Filters
Showing results (111-120 of 135) with videos related to
Page
of 14
Sort By:
Southern Medical Journal
|
March 1, 1980
Failure of prophylaxis for bacterial endocarditis: American Heart Association registry
A L Bisno, D T Durack, D W Fraser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 1993
Disseminated infection with rapidly growing mycobacteria
C W Ingram, D C Tanner, D T Durack, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1982
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci
R Auckenthaler, W R Wilson, A J Wright, et al.
The American Journal of Cardiology
|
February 15, 1996
Negative predictive value of the Duke criteria for infective endocarditis
G A Dodds, D J Sexton, D T Durack, et al.
Infection and Immunity
|
May 1, 1987
Efficacy of immune therapy in early experimental Naegleria fowleri meningitis
G J Lallinger, S L Reiner, D W Cooke, et al.
The American Journal of Medicine
|
January 1, 1993
Home intravenous antibiotic therapy
D T Durack, A W Karchmer, R Blair, et al.
Investigative Radiology
|
March 1, 1985
Computed tomographic evaluation of an experimental model for pyogenic liver abscesses
W M Thompson, R A Stude, M I McDonald, et al.
AIDS (London, England)
|
February 1, 1993
Intestinal parasites and HIV infection in Tanzanian children with chronic diarrhea
J P Cegielski, A E Msengi, C S Dukes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 30, 1998
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group
D J Sexton, M J Tenenbaum, W R Wilson, et al.
The American Journal of Medicine
|
July 20, 1982
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
J D Meyers, J C Wade, C D Mitchell, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 135) with videos related to
Sort By:
Page
of 14
Southern Medical Journal
|
March 1, 1980
Failure of prophylaxis for bacterial endocarditis: American Heart Association registry
A L Bisno, D T Durack, D W Fraser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 1, 1993
Disseminated infection with rapidly growing mycobacteria
C W Ingram, D C Tanner, D T Durack, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1982
Lack of in vivo and in vitro bactericidal activity of N-formimidoyl thienamycin against enterococci
R Auckenthaler, W R Wilson, A J Wright, et al.
The American Journal of Cardiology
|
February 15, 1996
Negative predictive value of the Duke criteria for infective endocarditis
G A Dodds, D J Sexton, D T Durack, et al.
Infection and Immunity
|
May 1, 1987
Efficacy of immune therapy in early experimental Naegleria fowleri meningitis
G J Lallinger, S L Reiner, D W Cooke, et al.
The American Journal of Medicine
|
January 1, 1993
Home intravenous antibiotic therapy
D T Durack, A W Karchmer, R Blair, et al.
Investigative Radiology
|
March 1, 1985
Computed tomographic evaluation of an experimental model for pyogenic liver abscesses
W M Thompson, R A Stude, M I McDonald, et al.
AIDS (London, England)
|
February 1, 1993
Intestinal parasites and HIV infection in Tanzanian children with chronic diarrhea
J P Cegielski, A E Msengi, C S Dukes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 30, 1998
Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group
D J Sexton, M J Tenenbaum, W R Wilson, et al.
The American Journal of Medicine
|
July 20, 1982
Multicenter collaborative trial of intravenous acyclovir for treatment of mucocutaneous herpes simplex virus infection in the immunocompromised host
J D Meyers, J C Wade, C D Mitchell, et al.
Page
of 14